Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid. 

 

There are currently no ongoing consultations.
 
0352-01 Initial Bis(2-ethylhexyl) phthalate 204-211-0 117-81-7 Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd; Colorite Europe Ltd. (withdrawn) Formulation of DEHP mixtures for application in immediate packaging of medicines and medical devices Opinion development Details
0352-02 Initial Bis(2-ethylhexyl) phthalate 204-211-0 117-81-7 Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd Use of DEHP-containing plastics for immediate packaging of medicinal products Opinion development Details
0352-03 Initial Bis(2-ethylhexyl) phthalate 204-211-0 117-81-7 Baxter SA; Baxter Healthcare SA; Gambro Dasco SpA; Baxter (Malta) Trading Co Ltd Use of DEHP-based mixtures as a lubricating/sealing agent for the insertion of port closures into empty bags and assembly/connection of parts, that are used in immediate packaging of medicines Opinion development Details
0353-01 Initial Tetraethyllead 201-075-4 78-00-2 Shell Nederland Raffinaderij B.V. Use of tetraethyl lead in the formulation of aviation fuel Opinion development Details
0354-01 Review report Chromium trioxide 215-607-8 1333-82-0 Airbus Helicopters Technik GmbH Use as a surface hardener (functional chrome plating) in the manufacture of helicopter transmissions and the maintenance of helicopters. Opinion development Details
0354-02 Review report Chromium trioxide 215-607-8 1333-82-0 Airbus Helicopters Technik GmbH Surface treatment (as corrosion inhibitor, no connection with functional chrome plating) in the manufacture of helicopter transmissions and the maintenance of helicopters. Opinion development Details
0355-01 Review report Sodium dichromate 234-190-3 10588-01-9 Airbus Helicopters Technik GmbH Surface treatment of metals (such as aluminium, steel, zinc, magnesium, titanium, alloys), composites and sealings of anodic films, in the production of transmissions for helicopters and in maintenance of helicopters. Opinions adopted Details
0356-01 Review report Sodium dichromate 234-190-3 10588-01-9 AD International BV Use of SDC in formulation of mixtures intended for supply for authorised uses Opinion development Details
0357-01 Review report potassium dichromate 231-906-6 7778-50-9 LYNRED Industrial use of potassium dichromate-based mixtures during the step of final etching of CZT layers during the production of opto-electronic components gathering a readout and an infrared detecting circuit with the MCT technology. Opinion development Details
0358-01 Review report Arsenic acid 231-901-9 7778-39-4 CIRCUIT FOIL LUXEMBOURG SARL Industrial use of arsenic acid for the treatment of copper foil used in the manufacture of printed circuit board. Opinion development Details
0359-01 Review report Chromium trioxide 215-607-8 1333-82-0 CIRCUIT FOIL LUXEMBOURG SARL Industrial use of chromium trioxide for the treatment of copper foil used in the manufacture of printed circuit board. Opinion development Details
0360-01 Initial 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 239-622-4 15571-58-1 Galata Chemicals GmbH; REAGENS SPA Formulation of liquid mixtures containing DOTE Opinion development Details
0360-02 Initial 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 239-622-4 15571-58-1 Galata Chemicals GmbH; REAGENS SPA; PMC Vlissingen Netherlands B.V. Formulation of PVC dry mixtures (granules and pellets) containing DOTE Opinion development Details
0360-03 Initial 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 239-622-4 15571-58-1 Galata Chemicals GmbH; REAGENS SPA; PMC Vlissingen Netherlands B.V. Industrial manufacture of PVC articles through extrusion, injection, calendering and coating using mixtures containing DOTE as stabilizer Opinion development Details
0361-01 Initial tetraethyllead 201-075-4 78-00-2 Trafigura Ventures V.B.V. Blending of TEL in Avgas formulations Opinion development Details
0362-01 Initial tetraethyllead 201-075-4 78-00-2 Warter Fuels Spółka Akcyjna FUEL FORMULATION WITH ADDED TETRAETHYL LEAD Opinion development Details
0363-01 Initial Chromium trioxide 215-607-8 1333-82-0 Ramboll Belgium BVBA (Indestructible Paints) Treatment of components used in industrial gas turbines and associated components using slurry coating products containing chromium trioxide to enhance corrosion resistance, chemical resistance, high temperature oxidation resistance, adhesion to components which produce a smooth finish and enhance the technical performance of turbines. Opinion development Details